Moderna, Inc. (MRNA) Stock Leaping Forward in Premarket, Here’s the Reason

 Moderna, Inc. (MRNA), a biotechnology company, has soared 5.07% in the premarket trading session. As a result, MRNA stock is trading at $309.74 at the time of the writing. The increase could be attributed to the company’s announcement of preliminary booster data to address the omicron variant. On Friday, MRNA closed the day at $294.80 […]